# Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

> **NCT02279134** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Zefen Xiao** · enrollment: 360 (estimated)

## Conditions studied

- Esophageal Neoplasms
- Esophageal Cancer

## Interventions

- **RADIATION:** Adjuvant Chemoradiation
- **RADIATION:** Adjuvant Radiation
- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin or Nedaplatin

## Key facts

- **NCT ID:** NCT02279134
- **Lead sponsor:** Zefen Xiao
- **Sponsor class:** UNKNOWN
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-10
- **Primary completion:** 2022-12
- **Final completion:** 2024-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2020-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279134, "Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02279134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*